Related Experiment Video
Updated: May 4, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome
Salina Siddiqui1, Juan Carlos Zenteno, Aine Rice
1*Section of Ophthalmology and Neuroscience, Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom; †Department of Ophthalmology, St James's University Hospital, Leeds, United Kingdom; ‡Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico; §Department of Genetics, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico; and ¶Department of Ophthalmology, Bradford Royal Infirmary, Bradford, United Kingdom.
Insights
Congenital hereditary endothelial dystrophy (CHED) patients with SLC4A11 mutations often develop sensorineural hearing loss, progressing to Harboyan syndrome. Monitoring CHED patients for hearing loss is recommended.
Area of Science:
- Genetics
- Ophthalmology
- Audiology
Background:
- Mutations in SLC4A11 cause rare genetic disorders affecting the cornea and hearing.
- Congenital hereditary endothelial dystrophy (CHED) and Harboyan syndrome are linked to homozygous SLC4A11 mutations.
- Fuchs endothelial corneal dystrophy (FECD) is associated with dominant SLC4A11 mutations.
Purpose of the Study:
- Investigate hearing loss progression in CHED patients.
- Assess carrier parents of CHED patients for signs of FECD.
- Analyze the role of SLC4A11 mutations in disease manifestation.
Main Methods:
- Genetic screening for SLC4A11 mutations in CHED patients.
- Audiometric testing to evaluate hearing function.
- Clinical examination and specular microscopy for patients and parents.
Main Results:
- SLC4A11 mutations confirmed in 4 CHED patients from 3 families.
- All patients exhibited sensorineural hearing loss, particularly at higher frequencies.
- Two carrier parents showed guttate lesions, suggesting potential FECD risk.
Conclusions:
- CHED with homozygous SLC4A11 mutations can progress to Harboyan syndrome with variable severity.
- CHED patients require monitoring for progressive hearing loss.
- Further research is needed to confirm FECD risk in carrier parents.
Purpose:
Homozygous mutations in SLC4A11 cause 2 rare recessive conditions: congenital hereditary endothelial dystrophy (CHED), affecting the cornea alone, and Harboyan syndrome consisting of corneal dystrophy and sensorineural hearing loss. In addition, adult-onset Fuchs endothelial corneal dystrophy (FECD) is associated with dominant mutations in SLC4A11. In this report, we investigate whether patients with CHED go on to develop hearing loss and whether their parents, who are carriers of an SLC4A11 mutation, show signs of having FECD.
Methods:
Patients with CHED were screened for mutations in the SLC4A11 gene and underwent audiometric testing. The patients and their parents underwent a clinical examination and specular microscopy.
Results:
Molecular analyses confirmed SLC4A11 mutations in 4 affected individuals from 3 families. All the patients were found to have varying degrees of sensorineural hearing loss at a higher frequency range. Guttate lesions were seen in 2 of the 4 parents who were available for examination.
Conclusions:
Our observations suggest that CHED caused by homozygous SLC4A11 mutations progresses to Harboyan syndrome, but the severity of this may vary considerably. Patients with CHED should therefore be monitored for progressive hearing loss. We could not determine conclusively whether the parents of the patients with CHED were at increased risk of developing late-onset FECD.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Huntington Disease l: Introduction
Diabetic Retinopathy
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Genetic Lingo
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

